Skip to content
10-Q

Quarterly Report

GREEN VISION BIOTECHNOLOGY CORP.

0001640334-20-001335

← back to feed
Filed
May 28, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 1, 2020 160.79M sh
Cash And Equivalents Q1 2019 · Mar 31, 2019 $13.45K
Cash And Equivalents Q1 2019 · Dec 31, 2018 $9.11K
Cash And Equivalents Q1 2019 · Mar 31, 2018 $19.91K
Cash And Equivalents Q1 2019 · Dec 31, 2017 $38.93K
Current Liabilities Q1 2019 · Mar 31, 2019 $9.76M
Current Liabilities Q1 2019 · Dec 31, 2018 $9.63M
Total Liabilities Q1 2019 · Mar 31, 2019 $9.76M
Total Liabilities Q1 2019 · Dec 31, 2018 $9.63M
Current Assets Q1 2019 · Mar 31, 2019 $44.22K
Current Assets Q1 2019 · Dec 31, 2018 $36.65K
Total Assets Q1 2019 · Mar 31, 2019 $3.27M
Total Assets Q1 2019 · Dec 31, 2018 $3.23M
Net Income Q1 2019 · Dec 31, 2018 −$1.36M
Net Income Q1 2019 · Mar 31, 2018 −$233.31K
Shares Diluted Q1 2019 · Mar 31, 2018 160.79M sh
Capex Q1 2019 · Mar 31, 2018 $637
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$122.68K
Stockholders Equity Q1 2019 · Mar 31, 2018 −$5.28M
Stockholders Equity Q1 2019 · Dec 31, 2017 −$5.09M
Eps Diluted Q1 2019 · Mar 31, 2018 −$0.15
Eps Basic Q1 2019 · Mar 31, 2018 −$0.15
Operating Income Q1 2019 · Mar 31, 2018 −$231.61K
Gross Profit Q1 2019 · Mar 31, 2018 $15.66K
Revenue Q1 2019 · Mar 31, 2018 $52.92K